{"title":"“结肠癌术前多探测器计算机断层扫描分期准确性”的勘误","authors":"","doi":"10.1111/codi.70123","DOIUrl":null,"url":null,"abstract":"<p>Olsen ASF, Gundestrup AK, Kleif J, Thanon T, Bertelsen CA. Accuracy of preoperative staging with multidetector computed tomography in colon cancer. Colorectal Dis. 2021;23:680-8.</p><p>Throughout the text, locally advanced colon cancer was incorrectly defined as T3 with 5 mm or more extramural tumour invasion (ETI) or T4. The correct definition was: “as T3 with more than 5 mm extramural tumour invasion (ETI) or T4”. This should have read as follows:</p><p>In paragraph 1 of the “Introduction” section: “Neoadjuvant chemotherapy might be beneficial to the small subgroup of patients with locally advanced colon cancer defined as clinical (c)T3 with more than 5 mm extramural tumour invasion (ETI) or cT4 [1–3].”</p><p>In paragraph 3 of the “Introduction” section: “Both studies and a metanalysis [12] concluded that MDCT was able to identify patients with locally advanced colon cancer (T3 with extramural tumour invasion of more than 5 mm or T4) and be reliable as the decision-making tool for including patients in the trial, but it is questionable whether these results can be applied to daily practice.”</p><p>In paragraph 4 of the “Methods” section: “The primary outcome of the study was the accuracy of MDCT to preoperatively identify those patients with locally advanced disease (defined as pT3 with ETI of more than 5 mm or pT4 tumour).”</p><p>In Figure 1, “ETI of more than 5 mm or T4” in the two boxes.</p><p>In the explaining text of Table 2: “Locally advanced disease was defined clinical or histopathologic as T3 tumour with an extramural tumour invasion of more than 5 mm or a T4 tumour.”</p><p>In paragraph 1 of the “Discussion” section: “The results show that MDCT can detect invasion beyond the muscularis propria (pT3–4 versus pT1–2) with a sensitivity of 73%, but it remains a challenge to identify patients with pT4 or pT3 with extramural tumour invasion of more than 5 mm, and especially to predict lymph node metastasis and thus UICC Stage I.”</p><p>We apologize for this error.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 5","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70123","citationCount":"0","resultStr":"{\"title\":\"Erratum to “Accuracy of preoperative staging with multidetector computed tomography in colon cancer”\",\"authors\":\"\",\"doi\":\"10.1111/codi.70123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Olsen ASF, Gundestrup AK, Kleif J, Thanon T, Bertelsen CA. Accuracy of preoperative staging with multidetector computed tomography in colon cancer. Colorectal Dis. 2021;23:680-8.</p><p>Throughout the text, locally advanced colon cancer was incorrectly defined as T3 with 5 mm or more extramural tumour invasion (ETI) or T4. The correct definition was: “as T3 with more than 5 mm extramural tumour invasion (ETI) or T4”. This should have read as follows:</p><p>In paragraph 1 of the “Introduction” section: “Neoadjuvant chemotherapy might be beneficial to the small subgroup of patients with locally advanced colon cancer defined as clinical (c)T3 with more than 5 mm extramural tumour invasion (ETI) or cT4 [1–3].”</p><p>In paragraph 3 of the “Introduction” section: “Both studies and a metanalysis [12] concluded that MDCT was able to identify patients with locally advanced colon cancer (T3 with extramural tumour invasion of more than 5 mm or T4) and be reliable as the decision-making tool for including patients in the trial, but it is questionable whether these results can be applied to daily practice.”</p><p>In paragraph 4 of the “Methods” section: “The primary outcome of the study was the accuracy of MDCT to preoperatively identify those patients with locally advanced disease (defined as pT3 with ETI of more than 5 mm or pT4 tumour).”</p><p>In Figure 1, “ETI of more than 5 mm or T4” in the two boxes.</p><p>In the explaining text of Table 2: “Locally advanced disease was defined clinical or histopathologic as T3 tumour with an extramural tumour invasion of more than 5 mm or a T4 tumour.”</p><p>In paragraph 1 of the “Discussion” section: “The results show that MDCT can detect invasion beyond the muscularis propria (pT3–4 versus pT1–2) with a sensitivity of 73%, but it remains a challenge to identify patients with pT4 or pT3 with extramural tumour invasion of more than 5 mm, and especially to predict lymph node metastasis and thus UICC Stage I.”</p><p>We apologize for this error.</p>\",\"PeriodicalId\":10512,\"journal\":{\"name\":\"Colorectal Disease\",\"volume\":\"27 5\",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-05-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70123\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/codi.70123\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/codi.70123","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Erratum to “Accuracy of preoperative staging with multidetector computed tomography in colon cancer”
Olsen ASF, Gundestrup AK, Kleif J, Thanon T, Bertelsen CA. Accuracy of preoperative staging with multidetector computed tomography in colon cancer. Colorectal Dis. 2021;23:680-8.
Throughout the text, locally advanced colon cancer was incorrectly defined as T3 with 5 mm or more extramural tumour invasion (ETI) or T4. The correct definition was: “as T3 with more than 5 mm extramural tumour invasion (ETI) or T4”. This should have read as follows:
In paragraph 1 of the “Introduction” section: “Neoadjuvant chemotherapy might be beneficial to the small subgroup of patients with locally advanced colon cancer defined as clinical (c)T3 with more than 5 mm extramural tumour invasion (ETI) or cT4 [1–3].”
In paragraph 3 of the “Introduction” section: “Both studies and a metanalysis [12] concluded that MDCT was able to identify patients with locally advanced colon cancer (T3 with extramural tumour invasion of more than 5 mm or T4) and be reliable as the decision-making tool for including patients in the trial, but it is questionable whether these results can be applied to daily practice.”
In paragraph 4 of the “Methods” section: “The primary outcome of the study was the accuracy of MDCT to preoperatively identify those patients with locally advanced disease (defined as pT3 with ETI of more than 5 mm or pT4 tumour).”
In Figure 1, “ETI of more than 5 mm or T4” in the two boxes.
In the explaining text of Table 2: “Locally advanced disease was defined clinical or histopathologic as T3 tumour with an extramural tumour invasion of more than 5 mm or a T4 tumour.”
In paragraph 1 of the “Discussion” section: “The results show that MDCT can detect invasion beyond the muscularis propria (pT3–4 versus pT1–2) with a sensitivity of 73%, but it remains a challenge to identify patients with pT4 or pT3 with extramural tumour invasion of more than 5 mm, and especially to predict lymph node metastasis and thus UICC Stage I.”
期刊介绍：
Diseases of the colon and rectum are common and offer a number of exciting challenges. Clinical, diagnostic and basic science research is expanding rapidly. There is increasing demand from purchasers of health care and patients for clinicians to keep abreast of the latest research and developments, and to translate these into routine practice. Technological advances in diagnosis, surgical technique, new pharmaceuticals, molecular genetics and other basic sciences have transformed many aspects of how these diseases are managed. Such progress will accelerate.
Colorectal Disease offers a real benefit to subscribers and authors. It is first and foremost a vehicle for publishing original research relating to the demanding, rapidly expanding field of colorectal diseases.
Essential for surgeons, pathologists, oncologists, gastroenterologists and health professionals caring for patients with a disease of the lower GI tract, Colorectal Disease furthers education and inter-professional development by including regular review articles and discussions of current controversies.
Note that the journal does not usually accept paediatric surgical papers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
